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ABSTRACT
Objectives: With the considerable increase of female participation in youth sports, it has become crucial for medical profes-
sionals, coaches and parents to improve their competitiveness by understanding the conditions for which these females 
are at elevated risk and mitigating possible health consequences.
The aim of this study was to evaluate the effect competitive sports have on the disorders of the menstrual cycle, to investi-
gate the frequency of PMS (premenstrual syndrome)/PMDD (premenstrual dysphoric order) in professional female athletes 
and to identify risk factors predisposing for PMS and PMDD. Additionally, the levels of selected hormones such as serum 
estradiol, FSH, LH and prolactin were investigated to identify any hormonal perturbances that might have influence or be 
the risk factors for menstrual dysfunctions. 
Material and methods: The study group consisted of 75 professional athletes (girls and young women at the age of 16–22) 
who lived on the territory of Silesia. The control group consisted of 50 girls and young women at the same age, who did not 
practice any sport. The research tools included daily diary of PMS symptoms created in line with The American College of 
Obstetricians and Gynecologists (ACOG) recommendations and ICD-10 diagnostic criteria, daily diary of PMDD symptoms 
created according to DSM-V diagnostic criteria of the American Psychiatric Association (APA) and premenstrual symptoms 
screening tool (PSST).
Results: The analysis of menstrual cycle disorders showed statistical significance for heavy menstrual bleeding (p = 0.01) 
and longer breaks between menstrual bleeds (p = 0.01). PMDD was diagnosed in 8% and PMS in more than 42% of re-
spondents. The incidence of PMDD was not at significant variance between the groups (9.33% in contrast to 6.0%), while 
incidence of PMS was statistically different in both groups (p = 0.045) (49.33% vs 32.0%). A significant correlation between 
PMS, average age (p = 0.00001) and menarche age (p = 0.03) in young active athletes has been shown. The risk of PMS 
increased with age (by 1.71 with each year) (p = 0.0007).
Conclusions: A number of other risk factors predisposing for PMS and PMDD has also been identified. The findings of these 
researches will enable the athletic care network to provide better care for young female athletes.
Key words: menstruation cycle; menstrual disorders; premenstrual syndrome; premenstrual dysphoric disorder; sex 
hormones
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INTRODuCTION
Over the past several decades there has been a dramatic 
increase in youth sport participation. The number of female 
athletes skyrocketed: a 2012 longitudinal national survey 
found that the number of high school aged girls participat-
ing in competitive sport has increased tenfold [1].
Unsurprisingly, girls and young women benefit from 
engaging in sport activities; they better their health and life 
skills as well as uncover their passions [2]. It is also impor-
tant because it increases their self-confidence. The direct 
relationship between athletics and women in leadership 
roles has been proved by a 2013 Erst and Young survey of 
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821 high-level executives, which demonstrated that 96% of 
the women in chief executive positions had played sport [3].
However, engaging in sport can also be a risk factor for 
unhealthy behaviours, high training loads and metabolic 
disturbances in a subset if vulnerable athletes [4]. An official 
document entitled Female Athletes Issues for the Team Phy-
sician: A Consensus Statement — 2017 Update confirms that 
female athletes suffer musculoskeletal injuries and medical 
problems that come from and/or impact athletic activity. 
It also highlights that team physicians are required to recog-
nize the gender-specific ramifications of a number of issues 
including menstrual dysfunctions because in the athlete, it 
is at the minimum two to three times more frequent than in 
the non-athlete. Female athletes are also at higher risk of 
primary and secondary amenorrhea [5].
Long-term training periods or participation at competi-
tions also weaken ovarian activity, which can manifest as 
luteal phase defect, irregular menstruation or amenorrhea. 
Regular intensive physical activities activate hypothalam-
ic-pituitary-adrenal axis, lower thyroid hormones, leptin, 
insulin growth factor and the secretion of growth hormone. 
Stress that usually accompanies competitions is yet another 
factor which intensifies menstrual disorders in girls and 
women who train intensively. Stress reaction causes changes 
in the cyclic and pulsatile secretion of GnRH, lowers the 
concentration of gonadotropins, raises the level of prolactin, 
growth hormone, testosterone, ACTH, adrenal steroids and 
endorphins [6, 7].
Moreover, epidemiologic studies showing that 15–20% 
of the general population of women of reproductive age 
meet the criteria of high susceptibility to PMS (premenstrual 
syndrome) and 3–8% of them meet PMDD (premenstrual 
dysphoric disorder) exposure conditions [8–10] which in-
dicates the need to investigate whether practicing com-
petitive sport might also be a risk factor for PMS and PMDD. 
These findings might prove important for athletes, parents, 
coaches and care providers to recognize and mitigate risks 
associated with the participation and be aware of the prac-
ticality of prevention and early detection of menstrual dys-
function to prevent serious health consequences.
The aim of this study was to evaluate the impact of 
practicing competitive sports on menstrual cycle disor-
ders, to investigate the frequency of PMS/PMDD in female 
professional athletes and to identify risk factors predispos-
ing for PMS and PMDD. Additionally, the levels of selected 
hormones such as serum estradiol, FSH, LH and prolactin 
were investigated to identify any hormonal perturbances 
that might have influence or be the risk factors for men-
strual dysfunctions. The findings were intended to aid the 
development of more effective prevention, early detection 
and treatment strategies for menstrual problems in female 
athletes.
MATeRIAl AND MeThODS 
Study population
The prospective study involved 125 girls and young 
women (16–22 years of age). The study group consisted of 
75 female professional athletes (girls and young women). 
The inclusion criteria: obtaining the informed consent for 
the examination, menstrual bleeds for notes than 2 years, 
the absence of systemic diseases, including endocrine dis-
orders, depressive, anxiety and personality disorders. Girls 
and young women were members of sport clubs and/or 
students of sport schools. They practiced athletics, including 
medium and long-distance runs. They were subject to two 
endurance improving training methods: continuous method 
and interval method, with diversification into light, moderate 
and heavy training loads and unification of exercise duration.
To be classified as a professional athlete the subject had 
to be a member of a sport club, take part in championships 
and attend minimum 4 two-hour trainings per week.
The control group consisted of 50 girls and young wom-
en who were not practicing any sports.
The mean age was 18.7 ± 1.9 years in the study group, 
and 18.5 ± 1.8 years in the control group. The difference 
was statistically insignificant. The study and control groups 
were also homogenous in terms of height and menarche 
age. Body weight was statistically significant (p = 0.001) 
while body mass index (BMI) was statistically insignificant 
between the groups (Tab. 1).
Research methods
The research tools included a questionnaire to obtain 
information about social and demographic characteristics, 
family history, the course of menstruation cycle, obstetrical 
and gynecological history, gynecological diseases, type of 
sport practiced, the time and intensity of trainings, life style, 
diet, stimulants used, present health condition, current medi-
cations and the occurrence of PMS and PMDD symptoms. 
Daily diary of PMS symptoms has been created in ac-
cordance with The American College of Obstetricians and 
Gynecologists (ACOG) recommendations and ICD-10 diag-
nostic criteria. ACOG asserts that PMS cannot be diagnosed 
unless one of the six psychological symptoms (depression, 
angry outbursts, irritability, anxiety, confusion, social with-
drawal) or one of the four physical symptoms (breast tender-
ness, abdominal bloating, headache, swelling of extremities) 
is observed. In order to diagnose PMS, the symptoms must 
present themselves 5 days before the menstruation period 
in every of the two successive menstrual cycles (prospec-
tively), they must lessen in 4 days following the onset of 
menstruation and cannot reappear until at least 13th day 
of menstruation cycle. 
Everyday diary of PMDD symptoms has been developed 
according to diagnostic criteria of the American Psychiatric 
505
Mariola Czajkowska et al., Menstrual disorders
www. journals.viamedica.pl/ginekologia_polska
Association (APA) — DSM-IV (Diagnostic and Mental Disor-
ders) [11–14].
Each subject had her estradiol, FSH, PH and PRL levels 
investigated. For this purpose, they had 5–6 mL of periph-
eral venous blood collected. Serum was separated by cen-
trifugation of venous blood clots collected into a dry tube 
by a CENTRIFUGE MPW 340 (3000 revolutions, 8 minutes) 
device. Until biochemical analysis, centrifuged blood was 
stored in eppendorfs and frozen at (-20°C).To avoid false 
positive results the blood was collected in the morning, 
after night rest, between the 2nd and 5th day of menstruation 
cycle, after fasting and following a 12 hour break from the 
gymnastic exercises. The stimulation of nipples was avoided 
8–12 hours before the test.
The concentration levels of estradiol, FSH, LH and prol-
actin in accordance with the norm for follicular phase were 
determined using Abbot ARCHITECT CMIA (chemilumins-
cencemicroparticle immunoassay) diagnostics. The preci-
sion of ARCHITECT Estradiol is ≤ 5 pg/mL for concentrations 
in the range of the low control (target 45 pg/mL) and ≤ 7% 
for concentrations in the range of the medium control (tar-
get 190 pg/mL) and high control (target 600 pg/mL). The 
analytical sensitivity of ARCHITECT Estradiol is ≤ 10 pg/mL.
The ARCHITECT FSH test has been developed to ensure 
the precision expressed by the total value of coefficient of 
variation of ≤ 10% for concentrations on the range of the low, 
medium and high control. Analytical sensitivity of Architect 
FSH is below 0.05 m IU/mL. The precision of ARCHITECT LH 
is ≤ 10% of the total coefficient of variation. Analytical sensitiv-
ity of Architect LH is below 0.07 m IU/mL. Analytical sensitivity 
of ARCHITECT Prolactin has been evaluated below 0.6 ng/mL. 
Statistical analysis
For statistical analysis Excel 2007 and STATISTICA 
9.0 were used. Continuous values were described by means 
of arithmetic mean, standard deviation and median. Statis-
tical comparison of the results Mann-Whitney U test and 
Kruskal-Wallis test were used. For the evaluation of statistical 
classification Fisher’s exact test, Chi2 with Yates correction 
and logistic regression were applied. P < 0.05 was assumed 
as the level of statistical significance.
ethical statement
All subjects gave their informed consent for inclusion 
before they participated in the study. The study was con-
ducted in accordance with the Declaration of Helsinki, and 
the protocol was approved by the Ethics Committee of the 
Medical University of Silesia (KNW/0022/KB1/8/11).
ReSulTS
Menstrual cycles 
The analysis of menstrual cycle disorders showed sta-
tistical significance for heavy menstrual bleeding (p = 0.01) 
and longer breaks between menstrual bleeds (p = 0.01). The 
study group was statistically more likely to suffer from hy-
permenorrhea and longer breaks in menstruation than the 
control group. For the remaining domains the differences 
were not statistically significant. The groups were homog-
enous in terms of the length of menstruation cycle and the 
severity of menstrual pain (Fig. 1).
Premenstrual syndrome and premenstrual 
dysphoric disorder
In accordance with APA and ACOG recommendations, 
PMDD was diagnosed in 8% and PMS in more than 42% of the 
whole research population. PMDD incidence did not signifi-
cantly differ between the groups (9.33% in the study group 
vs 6.0% in control group) as opposed to PMS incidence which 
was statistically different in both groups (p = 0.045) (49.33% 
in the study group vs 32.00% in control group) (Fig. 2).
Table 1. General characteristics of the study and control groups
Values Group Mean Standard deviation Median 5th percentile 95th percentile Mann–Whitney’s  u test
Age [years]
Studied 18.7 1.9 18.0 16.0 21.3
NS (p = 0.40)
Control 18.5 1.8 20.0 16.0 20.6
Height [cm]
Studied 170 6 171 158 178
NS (p = 0.18)
Control 169 6 170 159 178
Body weight [kg]
Studied 58.1 6.2 59.0 45.8 68.0
p = 0.001
Control 62.6 8.7 62.5 47.0 73.6
BMI
Studied 20.01 1.82 19.82 16.96 22.66
NS (p = 0.55)
Control 21.84 2.64 21.30 18.11 26.49
Menarche
Studied 13.3 1.4 13.0 11.0 15.0
NS (p = 0.06)
Control 12.9 1.2 13.0 11.0 15.0
BMI — body mass index; NS — not significant 
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To validate the occurrence of various types of PMS and 
PMDD a premenstrual symptoms screening tool (PSST) 
was used. It proved the previous lack of PMS and PMDD 
in women without any clinical symptoms in both groups 
and differentiated PMS and PMDD into various scenarios, 
including mild and severe PMS and PMDD. In a significant 
percentage of women in the study group (37.33%) and 
control group (26.00%) a mild PMS was diagnosed. The 
differences between the groups were statistically insig-
nificant (Fig. 3).
The analysis of selected parameters such as respondents’ 
age, their BMI, age of menarche, years in sport, frequency 
of training or coffee, alcohol and cigarettes consumption 
indicates that some might be risk factors for PMS and PMDD. 
The first investigated factors were subjects’ age, BMI 
and menarche age. A one-way analysis did not show any 
significant influence of these variables on PMDD prevalence. 
However, it presented a significant correlation between PMS, 
average age (p = 0.00001) and menarche age (p = 0.03) in girls 
and young women who were professional athletes. The risk of 
PMS increased with age (by 1.71 with each year; p = 0.0007). 
There was nothing statistically significant between the 
number of years in sport and PMDD prevalence was ob-
served. However, it must be noted that the greatest percent-
age of professional athletes suffering from PMDD practiced 
2 years (28.57%) and 7 years (28.57%) (Fig 4.) (Tab. 2).
The incidence of PMS was, on the other hand, sig-
nificantly associated with longer professional experience 
(p = 0.0001) in the study group. The highest percentage 
of girls with PMS diagnosis was observed among women 
practicing 2 years (18.92%) and 5 years (16.22%) (Fig. 5).
No statistically significant correlation between weekly 
number of trainings and PMDD prevalence was shown in 
the studied group while the percentage of subjects with 
diagnosed PMS was increasing proportionally to the increas-
ing number of trainings, with the highest value in case of 
7 trainings per week (p = 0.004) (Fig. 6).
There was no statistically significant effect of coffee, 
alcohol or cigarettes on PMDD incidence in either group 
Figure 1. Abnormalities in the menstruation cycle in the study and 
control groups. NS — not significant 
Figure 2. PMS and PMDD diagnosed according American Psychiatric Association and American College of Obstetricians and Gynecologists 
recommendations in both groups. PMDD — premenstrual dysphoric order; PMS — premenstrual syndrome
76.19% Test: p = 0.01 23.81%
Studied group Control group
Irregular menstruation
periods N = 49 (100%) 55.10% Test: NS (p = 0.45) 44.90%
Painful menstruation
periods N = 107 (100%) 57.94% Test NS (p = 0.31) 42.06%
Heavy menstruation
periods N = 50 (100%) 74.00% Test: p = 0.01 26.00%
Other present disorders
N = 23 (100%)
65.12% Test: NS (p = 0.45) 34.88%
Breakthrough bleeding
incidences N = 23 (100%) 73.91% Test: NS (p = 0.16) 26.09%
Longer breaks between
periods N = 42 (100%)
0% 100%
3200%
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Figure 4. The correlation between PMDD and the number of years in sport. NS — not significant; PMDD — premenstrual dysphoric order
PMDD: yes n = 7 (100%) PMDD: no n = 68 (100%)
Test: NS (p = 0.46)











































































(Tab. 3), however, higher frequency of PMS was noted in 
respondents who took coffee and alcohol more frequently 
and in greater amount (more than 3 cups of coffee per day 
and more than 500 mL of beer or 2 glasses of wine of 50 mL 
of stronger alcohol). No impact of cigarettes has been noted 
and none of the above correlations have been observed in 
the control group (Tab. 4).
Neither the regularity of meals nor weight-reducing diet 
had any statistically significant impact on the prevalence of 
PMS and PMDD in two groups.
Clinical analysis of selected sex hormones
Long-lasting periods of physical strain in women en-
gaged in competitive sports can temporarily impair the 
hormonal function of the ovaries. Therefore, the researchers 
decided to investigate whether excessive physical activity 
reduced the concentration of gonadotropins, estrogens and 
prolactin in women.
The study (N = 75) and control (N = 50) groups were 
homogenous in terms of FSH, LH, prolactin and estradiol 
levels determined in the first phase of menstrual cycle. 
Hormone levels in case of PMS were analysed. LH level was 
statistically different (p = 0.02) in patients with PMS in the 
control group. However, it does not seem to be of clinical 
relevance (Tab. 5 and 6).
Statistically significant correlation between the number 
of trainings and the level of estradiol was shown, with the 
lowest value in the case of 4 trainings per week (p = 0.03). 
The level of prolactin was statistically significant for the over-
all number of training hours per week (p = 0.003). The lowest 
prolactin level was obtained in girls practicing 12 hours 
a week. The findings from this study may encourage more 
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research into other hormones, such as testosterone, which 
was not investigated for this study, as none of the subjects 
manifested any androgenized features.
DISCuSSION
Following recent increase in the number of female 
athletes and expansion of female competitions there has 
been a great focus on supporting active girls and young 
women and improve their competitiveness [15]. Without 
opposition, numerous researchers highlight that a note-
Table 2. Age, BMI and menarche in the study and control groups
Study group
Values PMDD Mean Standard deviation Median 5th percentile 95th percentile Mann-Whitney’s  u test
Age [years]
Yes 19.7 2.0 20.0 17.0 21.7
NS (p = 0.14)
No 18.5 1.9 17.5 16.0 21.0
BMI 
Yes 20.77 1.97 19.67 18.99 23.49
NS (p = 0.49)
No 19.93 1.80 19.92 16.84 22.38
Menarche
Yes 13.4 2.0 13.0 11.3 16.4
NS (p = 0.86)
No 13.3 1.3 13.0 11.0 15.0
Control group
Values PMDD Mean Standard deviation Median 5th percentile 95th percentile Mann-Whitney’s  u test
Age [years]
Yes 20.0 0.0 20.0 20.0 20.0
NS (p = 0.20)
No 18.4 1.8 20.0 16.0 20.7
BMI 
Yes 20.32 1.30 20.98 19.04 21.14
NS (p = 0.29)
No 21.93 2.68 21.46 18.04 26.51
Menarche
Yes 13.0 1.0 13.0 12.1 13.9
NS (p = 0.83)
No 12.9 1.2 13.0 11.0 15.0
Study group
Values PMS Mean Standard deviation Median 5th percentile 95th percentile Mann-Whitney’s  u test
Age [years]
Yes 19.6 1.7 20.0 17.0 22.0
p = 0.00001
No 17.7 1.7 17.0 16.0 21.0
BMI 
Yes 19.76 2.18 19.69 16.43 23.91
NS (p = 0.22)
No 20.24 1.37 20.11 18.19 22.07
Menarche
Yes 13.7 1.6 13.0 11.8 17.2
p = 0.03
No 12.9 1.1 13.0 11.0 14.0
Control group
Values PMS Mean Standard deviation Median 5th percentile 95th percentile Mann-Whitney’s  u test
Age [years]
Yes 18.5 1.8 20.0 16.0 20.0
NS (p = 0.90)
No 18.5 1.9 20.0 16.0 21.0
BMI 
Yes 21.19 1.39 21.08 18.98 22.84
NS (p = 0.41)
No 22.14 3.03 21.63 17.79 27.64
Menarche
Yes 13.8 1.3 13.0 11.8 15.0
NS (p = 0.06)
No 12.6 1.1 13.0 11.0 14.0
BMI — body mass index; PMDD — premenstrual dysphoric order; PMS — premenstrual syndrome; NS — not significant 
worthy percentage of women engaged in various sport 
disciplines is afflicted by disorders of the menstruation cycle. 
So far, the greatest number of studies on the frequency of 
amenorrhea and oligomenorrhea have focused mostly on 
long-distance runners, marathon runners, gymnasts, swim-
mers and women whose profession also involved intensive 
physical activity, such as ballet dancers [16]. In the popula-
tion of Polish sportswomen, menstruation cycle disorders 
have been investigated in female sprinters, rowers, canoers, 
judokas, fencers, basketball and handball players [17, 18].
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Figure 6. PMS and PMDD versus the frequency of training. NS — not significant; PMDD — premenstrual dysphoric order; PMS — premenstrual 
syndrome
PMDD: test: NS (p = 0.13)  PMS: test: p = 0.004
The number of training days per week
PMDD yes n = 7 (100%) PMDD no n = 68 (100%) PMS yes n = 37 (100%) PMS no n = 38 (100%)

















This research involved professional young female 
athletes, including medium and long distance-run-
ners. It showed significantly longer breaks between men-
ses (p = 0.01) in women practicing sports as compared to 
women who didn’t practice any sport. The situation was 
similar in case of hypermenorrhea (p = 0.01). The remaining 
abnormalities such as irregular and painful menses were 
specific to more than a half of respondents who were ac-
tive in sports.
It should be noted that consequences of menstrual 
dysfunction might manifest as suppression of reproduc-
tive hormones and infertility, altered cardio-vascular risk 
factors (e.g. lipid profile, endothelial function) and lower 
BMD (bone mineral density). Considering the fact that the 
consequences of menstrual dysfunction on BMD may not be 
reversible in every respect, evaluation of bone health should 
be considered if menstrual disorders are prolonged [19]. 
Coaches and clinicians should also remember that female 
youth and adolescent athletes are at greater risk for certain 
types of injuries, including concussions, musculoskeletal 
injury and Female Athlete Triad, which consists of low energy 
availability with or without disordered eating, menstrual 
dysfunction and low bone mineral density [20]. Therefore, 
the etiology of menstrual dysfunction must be always con-
sidered multi-factorial and thoroughly investigated.
Numerous studies showed fully diagnosed PMDD in 
3–8% of women at reproduction age [21–25]. Robinson and 
Swindle confirmed an even significantly higher percentage 
Figure 5. The correlation between PMS and the number of years in sport. PMS — premenstrual syndrome
The numbers of years in sport
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Table 3. The impact of coffee, alcohol and cigarettes on prevalence of PMDD
Type of stimulant Frequency





No Yes No Yes
Coffee
Does not drink 41 5
NS (p = 0.70)
18 1
NS (p = 1.00)
Drinks 27 2 29 2
Cigarettes
Does not smoke 66 6
NS (p = 0.26)
41 2
NS (p = 0.57)
Smokes 2 1 6 1
Alcohol
Does not drink at all 30 2
NS (p = 0.21)
11 0
NS (p = 0.22)Drinks but only to give a toast 34 3 28 3
Drinks on regular basis 4 2 8 0
NS — not significant; PMDD — premenstrual dysphoric order
Table 4. The impact of coffee, alcohol and cigarettes on prevalence of PMS
Type of  stimulant Frequency





No Yes No Yes
Coffee
Does not drink 28 18
p = 0.03
10 9
NS (p = 0.12)
Drinks 10 19 24 7
Cigarettes
Does not smoke 37 35
NS (p = 0.61)
29 14
NS (p = 1.00)
Smokes 1 3 5 2
Alcohol
Does not drink at all 21 11
p = 0.03
9 2
NS (p = 0.13)Drinks but only to give a toast 16 21 18 13
Drinks on regular basis 1 5 7 1
NS — not significant; PMS — premenstrual syndrome








Yes 4.54 4.30 1.04 2.69 5.70
NS (p = 0.36)
No 5.01 5.03 1.17 2.66 6.67
Control
Yes 5.78 6.06 0.70 4.99 6.30
NS (p = 0.93)




Yes 2.73 2.26 1.41 1.07 5.22
NS (p = 0.30)
No 3.30 2.48 1.53 1.45 5.29
Control
Yes 4.03 2.88 2.06 2.80 6.41
NS (p = 0.90)




Yes 43.61 38.10 13.52 33.60 68.30
NS (p = 0.47)
No 50.28 45.90 28.11 8.80 74.20
Control
Yes 45.87 43.60 4.37 43.10 50.90
NS (p = 0.61)




Yes 9.48 7.79 3.76 6.27 14.53
NS (p = 0.16)
No 17.22 10.71 23.49 3.78 40.76
Control
Yes 12.49 9.01 7.05 7.86 20.61
NS (p = 0.28)
No 9.41 7.97 4.69 5.00 17.40
NS — not significant; PMDD — premenstrual dysphoric order
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(exceeding 16%) of women with diagnosed PMDD [21]. Epi-
demiologic studies indicate that 15–20% of menstruating 
women meet PMS criteria. The recognition rate is about 50% 
in women of reproductive age and 50–80% in girls [21, 26, 27]. 
However, this study is the first to confirm PMS frequency 
in active sportswomen according to ACOG criteria and to 
identify risk factors predisposing for both PMS and PMDD.
In accordance with APA and ACOG recommendations, 
PMDD was diagnosed in 8% and PMS in more than 42% of 
the whole research population. The study presented a sig-
nificant correlation between PMS, average age (p = 0.00001) 
and menarche age (p = 0.03) in girls and young women who 
were professional athletes. The risk of PMS increased with 
age (by 1.71 with each year) (p = 0.0007). The incidence 
of PMS was also significantly associated with longer pro-
fessional experience (p = 0.0001) in the study group and 
was significantly increasing proportionally to the increas-
ing number of trainings, with the highest value in case of 
7 trainings per week (p = 0.004).Higher frequency of PMS 
was noted in respondents who drank coffee and alcohol 
more frequently and in greater amount. These findings may 
encourage more research into other risk factors such as body 
composition, nutrition or psychological factors.
Hormone levels in sportswomen have also been evalu-
ated by numerous researchers. The recent studies claim that 
the concentration of prolactin may rise under the influence 
of physical effort (as opposed to energetic deficiency) but 
this phenomenon is not likely to cause menstruation distur-








Yes 4.85 4.84 1.45 2.28 8.84
NS (p = 0.23)
No 5.08 5.04 0.79 4.04 6.67
Control
Yes 5.73 5.91 0.84 4.08 6.81
NS (p = 0.54)




Yes 2.87 2.34 1.62 0.95 5.43
p = 0.02
No 3.61 3.36 1.32 1.96 5.29
Control
Yes 4.47 4.21 2.10 1.38 7.83
NS (p = 0.22)




Yes 49.95 39.8 35.76 4.10 178.0
NS (p = 0.35)
No 49.37 45.9 15.06 28.00 74.20
Control
Yes 46.68 43.60 13.67 28.50 73.10
NS (p = 0.86)




Yes 20.27 13.89 30.35 3.78 141.5
NS (p = 0.25)
No 12.82 10.42 9.35 3.78 40.76
Control
Yes 9.02 7.86 3.64 5.18 20.61
NS (p = 0.73)
No 9.86 7.97 5.31 4.39 22.91
NS — not significant; PMS — premenstrual syndrome
bances in physically active women. They also showed that 
prolactin levels are subject to minor short-term changes 
throughout the cycle and prolactin concentration in sports-
women with amenorrhea does not significantly differ from 
the prolactin concentration in menstruating women who 
do not practice any sport [28–33]. However, studies by both 
Bielecka et al. and Męczekalski et al. showed an increased 
prolactin level in female professional athletes, who were 
exposed to physical and psychological stress during sport 
competitions [30, 31, 34, 35]. This research showed that 
study and control groups were homogenous in terms of 
FSH, LH, prolactin and estradiol levels determined in the first 
phase of menstrual cycle, however it should be noted that it 
involved only single determination of prolactin levels. Daily 
concentration profiles might be more reliable, but they were 
not carried out in this study. 
This study has been also limited by the relatively small 
number of subjects, thus it cannot be related to the whole 
population of sportswomen unless further extended and 
the results are significantly dependent on the specific ques-
tionnaire which is based on the respondents’ subjective 
evaluation of the reported symptoms.
However, in none of the previously conducted studies 
was it ever attempted to verify the effects the physical ef-
fort made while engaging in competitive sports on the rate 
of occurrence of PMS as well as PMDD with accordance to 
APA and ACOG criteria. That is why the juxtaposition of daily 
prospective assessment of PMS and PMDD symptoms and 
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the application of the screening tool for premenstrual symp-
toms (PSST) prove to be a genuinely innovative approach. 
Findings from this research may encourage more re-
search into menstrual dysfunctions in female athletes to 
increase the awareness of their coaches and clinicians, who 
can better support them in enjoying full benefits of sport 
participation.
CONCluSIONS
Age, menarche age, the number of years in sport and 
the intensity of trainings increase the risk of PMS occurrence 
in young female athletes. The risk of PMDD is increasing 
with the age of girls who train intensively. The amount of 
consumed alcohol and coffee are significant risk factors for 
premenstrual tension syndrome and premenstrual dys-
phoric disorder in female athletes.
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